1.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

2.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

3.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

4.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

5.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

6.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

7.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

8.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

9.

Practice variations in the management of childhood nephrotic syndrome in the Netherlands

1.

Incidence of idiopathic nephrotic syndrome during the Covid-19 pandemic in the Paris area (France) and in the Netherlands

1.

A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients

2.

A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients

3.

A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients

4.

A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients

5.

A pre-transplantation risk assessment tool for graft survival in Dutch pediatric kidney recipients

1.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

2.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

3.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

4.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

5.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

6.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

7.

Lessons learned from efforts to improve the quality of care in children with end-stage renal disease in the Netherlands and Belgium

1.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

2.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

3.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

4.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

5.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

6.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

7.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

8.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

9.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study.

1.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

2.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

3.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

4.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

5.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

6.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

7.

Important differences in management policies for children with end-stage renal disease in the Netherlands and Belgium--report from the RICH-Q study

1.

Extensive Complement Analysis in a C3 Glomerulopathy Cohort of Dutch Children with Benign Outcome